← Insider Monitor
Ascendis Pharma A/S logo
ASND

Ascendis Pharma A/S

Nasdaq · Pharmaceutical Preparations

2
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Ascendis Pharma is a Denmark-based biopharmaceutical company that develops therapies using its TransCon drug delivery technology, focusing on treatments for growth hormone deficiency, endocrine disorders, and rare diseases.

Industry
Pharmaceutical Preparations
Headquarters
Hellerup
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
BIENAIME JEAN JACQUESInsiderBuy$270KAug 14, 2026
BIENAIME JEAN JACQUESInsiderBuy$222KAug 14, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for ASND.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable ASND activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.